Shionogi (Japan)
In research, Shionogi (Japan) stands highest in Medicine (#7,251 of 10,443 worldwide) and Health Sciences (#9,043 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Infectious Diseases — Infectious Diseases is 20.0× its share of world research.
- World rank, 2022–2025
- #8,997 of 28,054 · #4,427 all time
- Rank in Japan
- #230 of 1,070
- Research works
- 4.3k ▲ 48% vs 2013–17
- Citations
- 95k 22.0 per fractional work
- Top-10% rate
- 15.9% record average 16.5%
- Open access
- 45% world 28%
What is Shionogi (Japan) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,251 of 10,443 | 19.6% | 74 | #4205 | |
| Health SciencesDomain | #9,043 of 11,982 | 19.2% | 77 | #5309 |
Each strip is that field’s whole ranked pool, with the notch where Shionogi (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Shionogi (Japan) specialise in?
Where its research is concentrated relative to its size: Infectious Diseases takes 20.0× the share of its output that it takes of world research.
- Infectious DiseasesSubfield · 21.9 works20×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.5×
- Immunology and Microbiology 5.1×
- Chemistry 3.3×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Neuroscience 2.6×
- Medicine 2.4×
- Mathematics 1.6×
- Nursing 1.3×
- Dentistry 1.0×
- Materials Science 0.8×
- Economics, Econometrics and Finance 0.6×
- Decision Sciences 0.5×
- Psychology 0.5×
- Veterinary 0.4×
- Health Professions 0.4×
- Engineering 0.3×
- Agricultural and Biological Sciences 0.3×
- Computer Science 0.3×
- Chemical Engineering 0.2×
- Environmental Science 0.2×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Physics and Astronomy 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Shionogi (Japan)?
Ranked on the composite score, Yohko Yoshimura, Kazuo Tori and Hitoshi Minato lead among researchers whose main affiliation is Shionogi (Japan).
- 1 Yohko Yoshimura Japan · #144,739 worldwide 140 citations · 33 works
- 2 Kazuo Tori Japan · #145,084 worldwide 255 citations · 64 works
- 3 Hitoshi Minato Japan · #183,786 worldwide 104 citations · 24 works
- 4 Shujiro Seo Japan · #248,507 worldwide 133 citations · 24 works
- 5 Roger Echols Japan · #299,271 worldwide 132 citations · 22 works
- 6 Hitoshi Arita Japan · #342,038 worldwide 83 citations · 18 works
- 7 Eiji Kondo Japan · #355,595 worldwide 100 citations · 42 works
- 8 Akinori Arimura Japan · #377,563 worldwide 96 citations · 16 works
- 9 Shigeo Yagi Japan · #378,375 worldwide 92 citations · 29 works
- 10 Isao Horibe Japan · #397,318 worldwide 72 citations · 22 works
Which keywords describe research at Shionogi (Japan)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Pandemic, SARS-CoV-2, ACE2 Receptor, Vaccine, Immunity, Immune Response and Coronavirus.
- H1N1
- Respiratory
- Virus
- Genomics
- Infectious Diseases
- Drug Resistance
- Biosensors
- Pharmacokinetics
- Pathogenesis
- ESKAPE Pathogens
- Clinical Characteristics
- Antimicrobial Resistance
- Thrombosis
- COVID-19
- antibody
- Viral Transmission
- Coronavirus
- Immunity
- ACE2 Receptor
- Pandemic
- Epidemiology
- SARS-CoV-2
- Vaccine
- Immune Response
- Antibiotic Resistance
- Mutation
- spike protein
- Inflammation
- Pathophysiology
- Drug Discovery
- Cytokine Storm
- Multidrug-Resistant Bacteria
- Medicinal Chemistry
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Vaccine Development
- Antibodies
- Cognitive Impairment
- Influenza
- Biofilm Formation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology27▲ 4.2×40 topics
- Pandemic18▲ 10×7 topics
- SARS-CoV-217▲ 32×4 topics
- ACE2 Receptor14▲ 35×3 topics
- Vaccine12▲ 18×9 topics
- Immunity10▲ 15×5 topics
- Immune Response10▲ 11×11 topics
- Coronavirus9▲ 27×3 topics
- Antibiotic Resistance9▲ 15×6 topics
- Viral Transmission9▲ 37×3 topics
- Mutation8▲ 28×2 topics
- antibody8▲ 48×1 topic
- spike protein8▲ 48×1 topic
- COVID-197▲ 3.3×14 topics
- Inflammation7▲ 2.0×27 topics
- Thrombosis6▲ 13×3 topics
- Pathophysiology6▲ 12×3 topics
- Antimicrobial Resistance6▲ 18×4 topics
- Drug Discovery6▲ 16×6 topics
- Clinical Characteristics5▲ 26×1 topic
- Cytokine Storm5▲ 31×1 topic
- ESKAPE Pathogens5▲ 55×1 topic
- Multidrug-Resistant Bacteria5▲ 55×1 topic
- Pathogenesis5▲ 6.2×8 topics
- Medicinal Chemistry5▲ 11×6 topics
- Pharmacokinetics5▲ 11×4 topics
- Antibiotic Pharmacokinetics5▲ 97×1 topic
- Biosensors5▲ 5.5×4 topics
- Critically Ill Patients5▲ 97×1 topic
- Drug Resistance4▲ 9.9×6 topics
- Vaccine Development4▲ 11×6 topics
- Infectious Diseases4▲ 8.0×6 topics
- Antibodies4▲ 40×2 topics
- Genomics4▲ 7.4×4 topics
- Cognitive Impairment3▲ 8.1×4 topics
- Virus3▲ 22×3 topics
- Influenza3▲ 47×2 topics
- Respiratory3▲ 20×2 topics
- Biofilm Formation3▲ 27×3 topics
- H1N13▲ 60×1 topic
Which research topics does Shionogi (Japan) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Antibiotic Resistance in Bacteria and Antibiotics Pharmacokinetics and Efficacy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 8 works
- 2 COVID-19 Clinical Research Studies Infectious Diseases 5 works
- 3 Antibiotic Resistance in Bacteria Molecular Medicine 5 works
- 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 5 works
- 5 Influenza Virus Research Studies Epidemiology 3 works
- 6 SARS-CoV-2 detection and testing Infectious Diseases 3 works
- 7 Chemical Synthesis and Analysis Molecular Biology 3 works
- 8 Respiratory viral infections research Epidemiology 3 works
- 9 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
- 10 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shionogi (Japan)'s research output changed?
Output in 2018–2022 was 48% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Osaka
- The University of Osaka
- Osaka City University
- Kindai University
- National Cerebral and Cardiovascular Center
- Kansai Medical University
- Takeda (Japan)
- Osaka International Cancer Institute
- Osaka Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.